During this fireside chat we welcome Cadrenal Therapeutics, ticker symbol of CVKD on the Nasdaq. Joining us from the company is the company’s Chief Medical Officer, Dr. Douglas Losordo. Also joining us is Joe Pantginis. Joe is the Managing Director of Research at H.C. Wainwright, whom I’ve asked to moderate today’s fireside chat. Joe covers a wide array of healthcare companies there at H.C. Wainwright including Cadrenal.

This Fireside Chat was recorded during the Lytham Partners 2024 Investor Select Conference.